GILD - Gilead partnering with Cartography Biosciences to discover cancer therapies
2024-05-28 10:23:08 ET
More on Gilead Sciences
- Gilead Sciences: Disappointing Fundamentals And Sentiment, But Still Bullish
- Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows
- Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors
- Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
- Gilead touts additional data on liver disease asset seladelpar ahead of PDUFA date